Outcomes Associated with Tocilizumab Use in Patients with COVID-19 Infection Complicated by Severe AKI Requiring Continuous Renal Replacement Therapy: PO0154

Outcomes Associated with Tocilizumab Use in Patients with COVID-19 Infection Complicated by Severe AKI Requiring Continuous Renal Replacement Therapy: PO0154

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of the American Society of Nephrology 2021-10, Vol.32 (10S), p.102-102
Hauptverfasser: Ghosn, Muriel, Attallah, Nizar M., Hijazi, Fadi A., Madhyastha, Rakesh, Gupta, Sudeendra S., El Nekidy, Wasim
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 102
container_issue 10S
container_start_page 102
container_title Journal of the American Society of Nephrology
container_volume 32
creator Ghosn, Muriel
Attallah, Nizar M.
Hijazi, Fadi A.
Madhyastha, Rakesh
Gupta, Sudeendra S.
El Nekidy, Wasim
description
doi_str_mv 10.1681/ASN.20213210S1102b
format Article
fullrecord <record><control><sourceid>crossref</sourceid><recordid>TN_cdi_crossref_primary_10_1681_ASN_20213210S1102b</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_1681_ASN_20213210S1102b</sourcerecordid><originalsourceid>FETCH-crossref_primary_10_1681_ASN_20213210S1102b3</originalsourceid><addsrcrecordid>eNqdj0tOxDAQRL0AieFzAVZ9gQy2AwksowBihMQgEthGjukwjRI72A4o3IP7Yj4btmyqVaXqkh5jh4IvRXYqjorqZim5FKkUvBKCy3aLLQQ_zpIsy9Mdtuv9M-fiROb5gn2sp6DtgB4K760mFfAR3ihsoI6up_dpUC3cewQycKsCoQn-p1CuH1bniTiDlelQB7IGSjuMPenvkXaGCl_RIRTXK7jDl4kcmafYMYHMZCcfQ6P6qGOvNA5xGeoNOjXO-2y7U73Hg9-7x-TlRV1eJdpZ7x12zehoUG5uBG--oJsI3fyFTv_19Anzg2Qr</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Outcomes Associated with Tocilizumab Use in Patients with COVID-19 Infection Complicated by Severe AKI Requiring Continuous Renal Replacement Therapy: PO0154</title><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Ghosn, Muriel ; Attallah, Nizar M. ; Hijazi, Fadi A. ; Madhyastha, Rakesh ; Gupta, Sudeendra S. ; El Nekidy, Wasim</creator><creatorcontrib>Ghosn, Muriel ; Attallah, Nizar M. ; Hijazi, Fadi A. ; Madhyastha, Rakesh ; Gupta, Sudeendra S. ; El Nekidy, Wasim</creatorcontrib><identifier>ISSN: 1046-6673</identifier><identifier>DOI: 10.1681/ASN.20213210S1102b</identifier><language>eng</language><ispartof>Journal of the American Society of Nephrology, 2021-10, Vol.32 (10S), p.102-102</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Ghosn, Muriel</creatorcontrib><creatorcontrib>Attallah, Nizar M.</creatorcontrib><creatorcontrib>Hijazi, Fadi A.</creatorcontrib><creatorcontrib>Madhyastha, Rakesh</creatorcontrib><creatorcontrib>Gupta, Sudeendra S.</creatorcontrib><creatorcontrib>El Nekidy, Wasim</creatorcontrib><title>Outcomes Associated with Tocilizumab Use in Patients with COVID-19 Infection Complicated by Severe AKI Requiring Continuous Renal Replacement Therapy: PO0154</title><title>Journal of the American Society of Nephrology</title><issn>1046-6673</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNqdj0tOxDAQRL0AieFzAVZ9gQy2AwksowBihMQgEthGjukwjRI72A4o3IP7Yj4btmyqVaXqkh5jh4IvRXYqjorqZim5FKkUvBKCy3aLLQQ_zpIsy9Mdtuv9M-fiROb5gn2sp6DtgB4K760mFfAR3ihsoI6up_dpUC3cewQycKsCoQn-p1CuH1bniTiDlelQB7IGSjuMPenvkXaGCl_RIRTXK7jDl4kcmafYMYHMZCcfQ6P6qGOvNA5xGeoNOjXO-2y7U73Hg9-7x-TlRV1eJdpZ7x12zehoUG5uBG--oJsI3fyFTv_19Anzg2Qr</recordid><startdate>202110</startdate><enddate>202110</enddate><creator>Ghosn, Muriel</creator><creator>Attallah, Nizar M.</creator><creator>Hijazi, Fadi A.</creator><creator>Madhyastha, Rakesh</creator><creator>Gupta, Sudeendra S.</creator><creator>El Nekidy, Wasim</creator><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>202110</creationdate><title>Outcomes Associated with Tocilizumab Use in Patients with COVID-19 Infection Complicated by Severe AKI Requiring Continuous Renal Replacement Therapy</title><author>Ghosn, Muriel ; Attallah, Nizar M. ; Hijazi, Fadi A. ; Madhyastha, Rakesh ; Gupta, Sudeendra S. ; El Nekidy, Wasim</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-crossref_primary_10_1681_ASN_20213210S1102b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ghosn, Muriel</creatorcontrib><creatorcontrib>Attallah, Nizar M.</creatorcontrib><creatorcontrib>Hijazi, Fadi A.</creatorcontrib><creatorcontrib>Madhyastha, Rakesh</creatorcontrib><creatorcontrib>Gupta, Sudeendra S.</creatorcontrib><creatorcontrib>El Nekidy, Wasim</creatorcontrib><collection>CrossRef</collection><jtitle>Journal of the American Society of Nephrology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ghosn, Muriel</au><au>Attallah, Nizar M.</au><au>Hijazi, Fadi A.</au><au>Madhyastha, Rakesh</au><au>Gupta, Sudeendra S.</au><au>El Nekidy, Wasim</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Outcomes Associated with Tocilizumab Use in Patients with COVID-19 Infection Complicated by Severe AKI Requiring Continuous Renal Replacement Therapy: PO0154</atitle><jtitle>Journal of the American Society of Nephrology</jtitle><date>2021-10</date><risdate>2021</risdate><volume>32</volume><issue>10S</issue><spage>102</spage><epage>102</epage><pages>102-102</pages><issn>1046-6673</issn><doi>10.1681/ASN.20213210S1102b</doi></addata></record>
fulltext fulltext
identifier ISSN: 1046-6673
ispartof Journal of the American Society of Nephrology, 2021-10, Vol.32 (10S), p.102-102
issn 1046-6673
language eng
recordid cdi_crossref_primary_10_1681_ASN_20213210S1102b
source EZB-FREE-00999 freely available EZB journals; PubMed Central
title Outcomes Associated with Tocilizumab Use in Patients with COVID-19 Infection Complicated by Severe AKI Requiring Continuous Renal Replacement Therapy: PO0154
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T22%3A04%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-crossref&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Outcomes%20Associated%20with%20Tocilizumab%20Use%20in%20Patients%20with%20COVID-19%20Infection%20Complicated%20by%20Severe%20AKI%20Requiring%20Continuous%20Renal%20Replacement%20Therapy:%20PO0154&rft.jtitle=Journal%20of%20the%20American%20Society%20of%20Nephrology&rft.au=Ghosn,%20Muriel&rft.date=2021-10&rft.volume=32&rft.issue=10S&rft.spage=102&rft.epage=102&rft.pages=102-102&rft.issn=1046-6673&rft_id=info:doi/10.1681/ASN.20213210S1102b&rft_dat=%3Ccrossref%3E10_1681_ASN_20213210S1102b%3C/crossref%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true